LOS ANGELES, CA / ACCESS Newswire / February 4, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
If you purchased TransMedics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a ...
Shares of TransMedics, Group Inc. (NASDAQ: TMDX) suffered a sharp decline over the past two trading days following the release of a ...
Block & Leviton is investigating TransMedics Group, Inc. (Nasdaq: TMDX) for potential securities law violations. Investors who have lost money in their TransMedics ...
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ:TMDX). Such ...
TransMedics' stock price has dropped $9.84, or 13%, since Scorpion released a report, titled“Walk Like An Egyptian,” leveling serious allegations against the company, including fraud ...
TMDX recently issued a statement refuting the claims made in a report by short-seller Scorpion Capital on Jan. 10, 2025, stating them as inaccurate and misleading. Per the statement issued, ...
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of TransMedics Group, Inc. resulting from allegations that ...
We maintain cautious stance on TransMedics investment due to high-risk factors. Read here for an analysis of TMDX stock drop and future prospects.
Last Friday, Scorpion Capital published a 342-page short report -- yes, 342 pages! -- detailing an alleged six-month investigation into TransMedics and its business practices. TransMedics has ...
Deep-pocketed investors have adopted a bullish approach towards TransMedics Gr TMDX, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled ...
Detailed price information for Transmedics Group Inc (TMDX-Q) from The Globe and Mail including charting and trades.